Retatrutide price in Canada
Prices are in Canadian dollars per lyophilized vial. Larger vials cost less per milligram.
| Vial size | Price (CAD) | Price per mg | Stock |
|---|---|---|---|
| 5 mg | $63.99 | $12.80 | In stock |
| 10 mg | $87.99 | $8.80 | In stock |
| 30 mg | $187.99 | $6.27 | In stock |
| 60 mg | $297.99 | $4.97 | In stock |
Retatrutide clinical trial status (2026)
Retatrutide (LY3437943) is an investigational Eli Lilly compound that activates the GIP, GLP-1 and glucagon receptors. It has not been approved by Health Canada and is sold here for laboratory research only.
- Phase 2 (Jastreboff et al., NEJM 2023): 338 adults with obesity; mean weight reduction of 24.2% at 48 weeks on 12 mg.
- Phase 3 TRIUMPH-1 (Lilly, May 2026): 2,339 adults; mean weight reduction of 28.3% at 80 weeks on 12 mg, versus 2.2% on placebo.
- Phase 3 TRIUMPH-2 and TRIUMPH-3 (Lilly, July 2026): 80 weeks on 12 mg; 20.8% vs 4.0% on placebo in adults with type 2 diabetes (n=1,152) and 22.6% vs 3.2% in adults with severe obesity and cardiovascular disease (n=1,949).
- Lilly says it plans to submit retatrutide to the FDA in the first quarter of 2027.
Phase 3 percentages are the sponsor's efficacy-estimand results (participants who stayed on treatment), as reported in Lilly press releases.
More detail: retatrutide dosage and reconstitution guide · retatrutide vs semaglutide vs tirzepatide
Reta Peptide: Product Specifications and Research Context
Anglo Peptides Canada supplies retatrutide research peptide in 5 mg, 10 mg, 30 mg and 60 mg lyophilized vials for Canadian laboratories. Retatrutide, often shortened to reta peptide, appears in the scientific literature as LY3437943. Each size describes the nominal contents of one vial, not a clinical dose or treatment recommendation.
| Listed vial amounts | 5 mg, 10 mg, 30 mg and 60 mg; availability varies by option. |
|---|---|
| Product form | Lyophilized powder for laboratory research. |
| Price and availability | Prices are shown in Canadian dollars. Select a vial size above for its current price and stock status. |
| Analytical documentation | Request the COA for the current product and lot. Check that the report identifies the same batch as the vial. |
| Shipping | Read shipping options and delivery terms. Delivery timing depends on the destination and carrier. |
Retatrutide Mechanism and Current Evidence
Retatrutide acts at three receptors: GIP, GLP-1 and glucagon. Semaglutide targets GLP-1; tirzepatide targets GIP and GLP-1. The additional receptor activity makes retatrutide a distinct research compound. It does not establish that it will outperform another compound in every experiment or clinical setting. The original discovery study describes its pharmacology.
Current retatrutide research
Evidence checked September 6, 2026. Peer-reviewed evidence now includes the 2023 obesity trial, the 2024 liver-fat substudy and the June 2026 Phase 3 TRANSCEND-T2D-1 trial in type 2 diabetes. Lilly has also announced results from the TRIUMPH obesity program; sponsor announcements and full journal reports carry different levels of detail.
The studies concern an investigational medicine used under trial conditions; they do not verify the identity, sterility, safety or clinical equivalence of an online research vial. Read the Lancet Phase 3 paper.
The Research Use tab summarizes individual studies and their limits. For the complete timeline, results and Canadian status, read the retatrutide clinical trials and research guide.
Purity, Batch COA and Third-Party Testing
Start with the compound name and lot number, then check the testing laboratory, report date and methods. A chromatographic purity percentage is different from measured vial content. Mass-spectrometry evidence, quantity, sterility and endotoxin results answer different questions and should be read separately when reported.
Use the Certificate of Analysis request form to obtain the report for your retatrutide vial. Include the exact vial size and ask for the current shipping batch, or provide the lot code from your vial. If the directory does not list your size, enter it in the request message. Match the laboratory report to the supplied lot before relying on a specific test claim. The molecular references in the Specifications tab describe the literature compound and do not certify the contents of a particular vial.
Retatrutide Canada: Forms, Strengths and Comparisons
Anglo Peptides offers the same research compound as lyophilized powder in 5 mg, 10 mg, 30 mg and 60 mg vials. The difference between these options is the nominal amount per vial. Vial amount does not describe a prepared solution’s concentration; laboratory staff calculate that from the amount of material and final solution volume. For the current retatrutide price in Canada, select a size above to view its CAD price and stock status. Compare vial amount and batch documentation alongside price when planning laboratory purchases.
Use the tirzepatide vs retatrutide research comparison to compare evidence and receptor targets. The semaglutide, tirzepatide and retatrutide overview adds the single-receptor comparator. Product options are grouped in the metabolic and fat-loss research category.
Buying retatrutide online in Canada
Select a vial size to check the current retatrutide price in Canada, stock status and available quantity. Review the matching batch documentation and Canadian shipping terms before ordering. To compare other laboratory materials, browse Buy Peptides Canada.
Reconstitution, Stability and Laboratory Storage in Canada
Follow the vial label, batch documentation and your laboratory’s validated handling procedure. Before reconstitution, confirm the material form, solvent compatibility and storage requirements for the supplied lot. Request missing handling information from Anglo Peptides support before preparing the material.
This page does not establish a universal storage temperature, shelf life or stability period after reconstitution. Laboratory staff should document the solvent, concentration, preparation date and storage conditions, and use stability data applicable to their method. The Specifications tab provides the molecular reference and batch-documentation requirements.
Use the peptide calculator to check mass, volume and concentration calculations for an established laboratory protocol. The calculator does not determine solvent compatibility, stability or a suitable research method.
Research use only. Retatrutide remains investigational. This product is not supplied as an approved medicine, and clinical trial results do not authorize human or veterinary use. Current developer status.





James T. –
Second time ordering reta from Anglo and the quality is still the best I’ve found in Canada. Powder reconstituted perfectly, clear solution every time. Had it in two days. Solid company all around.
Priya S. –
Best retatrutide I have tried from a Canadian source. Came same day, packaging was tight, reconstituted with no issues. On my third vial now and the quality is the same every time.
Omar K. –
Really impressed. Came packaged well and shipped same day. The 10mg vial is great value compared to what I was paying at other sources. Anglo is my go-to now.
Wei L. –
Good product, shipped quick. Had it within 48 hours of ordering, reconstituted cleanly with no cloudiness. Only wish they offered a larger vial option but the quality is solid.
Luke A. –
Ordered late Wednesday, had it Thursday. Clean powder, dissolved perfectly. Anglo is the real deal for reta in Canada, nothing else comes close at this price.
Olivia T. –
Incredibly rare to find research-grade Retatrutide made in Canada. Anglo Peptides nailed it, proper COA from Janoshik, clean reconstitution, and lightning-fast Xpresspost shipping.
Henry S. –
The 10mg vial is excellent. Dissolved cleanly and the documentation is thorough. Knowing it is manufactured in Canada gives me a lot of confidence in the supply chain.